Michael Hummelsberger Selected Research

Neoplasms (Cancer)

1/2013

Granocyte-colony stimulating factor (G-CSF) has significant efficacy as secondary prophylaxis of chemotherapy-induced neutropenia in patients with solid tumors: results of a prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Hummelsberger Research Topics

Disease

2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 01/2023
1	Hepatitis 10/2023
1	Melanoma (Melanoma, Malignant) 10/2023
1	Neutropenia 01/2013
1	Neoplasms (Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

1	Immune Checkpoint InhibitorsIBA 10/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2023
1	pembrolizumabIBA 10/2023
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2023
1	LenograstimIBA 01/2013
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2013
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2013

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2023 - 01/2013
1	Chemoradiotherapy 01/2024
1	Therapeutics 10/2023
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2023
1	Drug Tapering 01/2013